Nav: Home

MDI Biological Laboratory providing incubator space to Coagulation Sciences LLC

January 25, 2017

BAR HARBOR, MAINE -- The MDI Biological Laboratory has announced that it is providing incubator space and associated scientific resources on its Bar Harbor campus to Coagulation Sciences LLC a Riverdale, N.Y- based development-stage medical device company.

Coagulation Sciences is developing the Multiple Coagulation Test System (MCTSTM) to help hospitals minimize or eliminate unnecessary blood transfusions and their associated risks by providing information to physicians to arrest bleeding more rapidly.

Michael Kagan, Coagulation Sciences' director of product development, an engineer and Maine resident, hopes to establish manufacturing of the MCTSTM instrument and its disposable test cartridge in Maine. Kagan chose the incubator space at the MDI Biological Laboratory because of its location and the institution's commitment to developing a vibrant life sciences ecosystem in Maine.

"Maine needs to develop a support system to promote innovation and commercialization if it is going to grow its life sciences sector," Kagan said. "An important step is providing the incubator space and expertise to move a product through its development cycle. The MDI Biological Laboratory has the core laboratory facilities, infrastructure and access to expertise that will help us take Coagulation Sciences to the next level. This space allows us to expand our development efforts without additional capital equipment."

Coagulation Sciences is representative of the trend toward personalized medicine, or the tailoring of treatments to individual needs. Current tests to determine if transfusions are needed are often non-specific or too slow to inform transfusion decisions. As a result, 30 to 40 percent of blood transfusions are unnecessary. The company's automated analytical system will have the ability to determine within minutes if a coagulation disorder is truly present, and, if so, help define the nature of the problem so that the physician can make an informed decision regarding treatment.

The MDI Biological Laboratory is an independent nonprofit biomedical research institution focused on basic discovery, translation of discoveries into technologies that improve human health and driving innovation and entrepreneurship through interdisciplinary research, training and network-building. The institution's research and development activities are focused on regenerative medicine and its scientists are pioneering new approaches to treating devastating diseases like heart attack.

"Our goal is to help create an entrepreneurial ecosystem that nurtures innovation in the life sciences by providing a collaborative environment and by connecting entrepreneurs with the resources they need," said Kevin Strange, Ph.D., MDI Biological Laboratory president. "Coagulation Sciences has developed a new technology that will revolutionize the way we manage blood transfusions and is seeking to manufacture its device in Maine. This is exactly the type of company we want to help support."

Other innovative startups that the MDI Biological Laboratory has helped to launch and/or grow include RockStep Solutions, a life sciences-based software development startup; Anecdata, a data collection web application for crowd sourcing scientific and other types of data; and Novo Biosciences, the institution's first for-profit spin-off, which is developing drug therapies to reactivate and stimulate the body's innate healing abilities.

"Maine's enviable quality of life, Yankee work ethic and outstanding research and educational institutions can be leveraged to build a thriving life sciences industry sector," Kagan says. "But continued investment in the infrastructure and resources to attract and support new life sciences enterprises and the development of a technology-focused entrepreneurial culture is critical."
The MDI Biological Laboratory, located in Bar Harbor, Maine, is an independent, non-profit biomedical research institution focused on increasing healthy lifespan and increasing our natural ability to repair and regenerate tissues damaged by injury or disease. The institution develops solutions to complex human health problems through research, education and ventures that transform discoveries into cures. For more information, please visit

Mount Desert Island Biological Laboratory

Related Blood Transfusions Articles:

Giving trauma patients blood pressure stabilizing hormone cuts transfusions by half
Giving trauma patients with severe blood loss the hormone arginine vasopressin (AVP) cut the volume of blood products required to stabilize them by half, according to results of a new, first-of-its-kind clinical trial from Penn Medicine.
Of mice and babies: New mouse model links transfusions to deadly infant digestive disease
Physicians have long suspected that red blood cell transfusions given to premature infants with anemia may put them in danger of developing a potentially lethal inflammatory disease of the intestines.
Postpartum transfusions on the rise, carry greater risk of adverse events
Women who receive a blood transfusion after giving birth are twice as likely to have an adverse reaction related to the procedure, such as fever, respiratory distress, or hemolysis (destruction of red blood cells), compared with non-pregnant women receiving the same care, according to a new study published today in Blood Advances.
Impeding white blood cells in antiphospholipid syndrome reduced blood clots
A new study examined APS at the cellular level and found that two drugs reduced development of blood clots in mice affected with the condition.
Transfusions with older blood linked to adverse events, death, new study finds
Major trauma victims who receive transfusions of packed blood 22 days old or older may face increased risk of death within 24 hours, according to a new study in Annals of Emergency Medicine.
Blood management program safely reduces transfusions in orthopedic patients
A patient blood management program designed to limit the amount of transfused blood orthopedic patients undergoing common surgeries such as hip and knee replacement receive was associated with fewer transfusions, reduced blood use and improved outcomes, reports a study published in the Online First edition of Anesthesiology, the peer-reviewed journal of the American Society of Anesthesiologists (ASA).
Turbulence allows clinical-scale platelet production for transfusions
Turbulence is a critical physical factor that promotes the large-scale production of functional platelets from human induced pluripotent stem cells, researchers in Japan report July 12 in the journal Cell.
New era for blood transfusions through genome sequencing
In a new study, investigators from Brigham and Women's Hospital and Harvard Medical School, as well as from the New York Blood Center have leveraged the MedSeq Project -- the first randomized trial of whole genome sequencing in healthy adults -- to develop and validate a computer program that can comprehensively and cost-effectively determine differences in individuals' blood types with more than 99 percent accuracy.
New research: High risk of malaria transmission after blood transfusions in sub-Saharan Africa
A new study suggests that in high transmission areas of sub-Saharan Africa, nearly one in four blood bank supplies contain the parasites that cause malaria.
Blood stored longer may be less safe for patients with massive blood loss and shock
In a collaborative study using a mouse model, researchers have found mechanistic links between older stored red blood cell transfusions and subsequent bacterial pneumonia.
More Blood Transfusions News and Blood Transfusions Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

In & Out Of Love
We think of love as a mysterious, unknowable force. Something that happens to us. But what if we could control it? This hour, TED speakers on whether we can decide to fall in — and out of — love. Guests include writer Mandy Len Catron, biological anthropologist Helen Fisher, musician Dessa, One Love CEO Katie Hood, and psychologist Guy Winch.
Now Playing: Science for the People

#542 Climate Doomsday
Have you heard? Climate change. We did it. And it's bad. It's going to be worse. We are already suffering the effects of it in many ways. How should we TALK about the dangers we are facing, though? Should we get people good and scared? Or give them hope? Or both? Host Bethany Brookshire talks with David Wallace-Wells and Sheril Kirschenbaum to find out. This episode is hosted by Bethany Brookshire, science writer from Science News. Related links: Why Climate Disasters Might Not Boost Public Engagement on Climate Change on The New York Times by Andrew Revkin The other kind...
Now Playing: Radiolab

Breaking Bongo
Deep fake videos have the potential to make it impossible to sort fact from fiction. And some have argued that this blackhole of doubt will eventually send truth itself into a death spiral. But a series of recent events in the small African nation of Gabon suggest it's already happening.  Today, we follow a ragtag group of freedom fighters as they troll Gabon's president - Ali Bongo - from afar. Using tweets, videos and the uncertainty they can carry, these insurgents test the limits of using truth to create political change and, confusingly, force us to ask: Can fake news be used for good? This episode was reported and produced by Simon Adler. Support Radiolab today at